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Adverse effects of nasal continuous positive airway
pressure therapy in sleep apnoea syndrome
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Abstract
Nasal continuous positive airway pressure (nCPAP) is now the treatment of choice for patients with sleep
apnoea syndrome. Side-effects and adverse reactions have been described in isolated reports with this
device. We have, therefore, systematically studied the side-effects of nCPAP therapy in 300 consecutive
patients referred to the London Chest Hospital Ventilatory Support Unit. Ninety-six per cent of patients '
complained of at least one side-effect resulting from the therapy, with 45 per cent complaining of a side-
effect specific to the nasal mask. There was no correlation between the side-effects and level of pressure
used during nCPAP. The rate of compliance remained high in spite of the side-effects, with a daily use of
7.8 hours (SD 8.05) and with 83 per cent of the patients using the device every night. Although nCPAP
treatment remains acceptable to most patients there exists a high incidence of adverse effects.
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Introduction
Sleep apnoea syndrome (SAS) is defined by the
occurrence of more than five apnoeas per hour of
sleep (Guilleminault et al., 1978). Both cardiovascu-
lar and neuropsychological morbidity as well as
considerable sleep disturbances have been demon-
strated in patients with SAS who are untreated
(Koskenvuo et al., 1987; Bedard et al., 1991) together
with a higher risk of accidents while driving (Findley
et al., 1988). There is, however, no effective
pharmacological treatment for SAS (Strohl et al.,
1986) and surgery such as uvulopalatopharyngo-
plasty (U3P) has been found of benefit in less than
50 per cent of unselected patients (Rodenstein,
1992). Only a few patients with severe SAS need
referral for more advanced surgery (Riley et al.,
1990). For these reasons, nasal continuous positive
airways pressure is currently the first line therapy in
moderate to severe SAS (Sullivan et al., 1981).
Nasal CPAP creates a positive pressure in the
upper airways and provides a 'pressure splint' to
eliminate apnoea (Kryger, 1994). It may also
increase functional residual capacity and reflexly
dilate the pharynx (Hoffstein et al, 1984). In SAS,
nCPAP is usually considered when the apnoea-
hypopnoea index (the mean number of episodes of
apnoea or hypopnoea per hour of sleep) is greater
than 20. Although nasal CPAP is effective in
reducing sleep apnoea syndrome it is frequently
rejected by patients, partly because of the unwieldy
and inconvenient nature of the treatment (Rauscher
etal., 1991). Use of nCPAP is likely to be determined
by the perceived benefits to the patient as well as the
drawbacks of treatment, but the nature of these
factors is not well understood.
Studies of CPAP use and its effects are highly
variable in terms of patient selection and outcome
measures employed (Engleman et al., 1994). CPAP
compliance and acceptance is also variable with
compliance dictated by side-effects in some studies
and not in others (Kribbs et al., 1993). Even though
CPAP is effective, compliance has been shown to
vary from centre to centre and this may be due to
staff skill and experience in initiating therapy, the
adequacy of follow-up and perhaps, the type of
CPAP device and mask used.
The present paper presents the results of a survey
designed to study the adverse effects and the
compliance with CPAP therapy in a large popula-
tion. We believe our study has been performed on
the largest patient sample to be conducted at a single
centre.
Methods
All patients treated with nCPAP for a minimum of
six months or more, at the London Chest Hospital
over a 10-year period were included in the study.
These patients were referred to the sleep laboratory
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with a suspicion of SAS and in all cases underwent a
sleep study with chest wall movement, airflow and
overnight oxygen saturation (SaO2) monitoring prior
to starting treatment. All had a diagnosis of OSA
made by standard criteria followed by a nCPAP
overnight trial. Almost all the patients were using
second generation CPAP machines and silicone nasal
masks as opposed to individually designed ones
('SOFTSTART, Devilbiss Ltd, West Midlands, UK.
(85 per cent) and 'RESPIRONICS', Medic-Aid Ltd.,
West Sussex, UK. (15 per cent)). The pressure setting
of the machine was adjusted to the level of pressure
sufficient to abolish apnoeas and restore a correct
sleep quality as assessed by repeat sleep studies.
All patients were regularly followed up in out-
patients and machines serviced annually. Patients
were advised to contact the clinical team if they
experienced any problem with the machines. Faulty
equipment was immediately replaced.
A questionnaire was sent to all the patients who
had used nCPAP between January 1989 and
November 1998 including those who had finished
treatment at the time of the study. The questionnaire
asked about compliance and periodicity of the use of
nCPAP. Side-effects examined in detail included
adverse effects of the nasal mask such as allergy,
discomfort to the bridge of the nose, pain in the teeth
or gums and air leaks near the eyes or over the face.
We also enquired about dryness of the nose or
mouth in the mornings on wakening, symptoms of
sinusitis, sneezing, nasal drip, nasal congestion, nasal
bleeding (epistaxis) and air swallowing (aerophagia).
The questionnaire is detailed in Appendix I.
Statistical analysis
Categorical variables were binary coded for data
analysis and inter-relationships explored by
Spearman's correlations. Variables which showed
significant univariate correlation with compliance
were entered into a backward multiple logistic
regression in order to determine which had inde-
pendent effects on compliance.
Results
Of 354 patients issued with the questionnaires, 301
returned the completed forms (85.71 per cent). The
majority of those who were non-responders had
changed their address and could not be contacted.
Included were 271 males and 30 females (mean age
54 years ± 11.16, range 26 years to 80 years). Two
hundred and twenty-five patients (75 per cent) were
obese with a mean BMI (body mass index) of 31.55
kg m2 (range 24.09 to 41.17 kg m2).
The average self-reported daily use of nCPAP by
the patients was 7.8 ± four hours with 83 per cent of
the patients using the device every night. This
duration of use could not be independently corrobo-
rated as all the CPAP machines did not have an in-
built electrical run-time recording facility. Eight
patients (<three per cent) stated that they no longer
used the machines and of these five gave no reason.
Of the remaining three patients, two cited lack of
benefit and the remaining one cited frequent awaken-
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FIG. 1
Side-effects of nCPAP.
ings with use of the machine. Nine patients (three per
cent) reported the use of nocturnal sedatives in order
to tolerate the noise of the machine.
Two hundred and eighty-eight patients (96 per
cent) complained of at least one side-effect resulting
from the therapy. The percentage of patients
suffering from adverse effects is summarized in
Figure 1. The side-effects could be categorized as
either being due to the nasal mask (Figure 2), to
local intra-nasal adverse effects (Figure 3) or to
problems due to the noise and bulk of the machines
(Figure 4). In addition, 45 per cent of the patients
complained of at least one side-effect due to the
nasal mask (Figure 2) of which 162 (54 per cent)
found the silicone mask uncomfortable and had it
adjusted with benefit. Eighty-four (26.8 per cent) of
the patients also reported allergic phenomena with
the silicone mask and 156 (52 per cent) complained
of pain or abrasion over the bridge of the nose.
Seventy-eight (26 per cent) of the users also
complained of air leaks from around the mask on
to the eyes and the face leading to soreness of the
eyes in the mornings.
One hundred and thirty-eight patients (46 per
cent) also complained of dryness in the nose, while
210 (70 per cent) reported dryness of the mouth in
the mornings. Eighty-seven (29 per cent) also
complained of excessive sneezing, 102 (34.5 per
cent) reported rhinorrhoea and 129 (43 per cent)
experienced nasal blockage and congestion. Many
users (108; 36 per cent) required some form of
topically acting nasal steroid spray. Frank epistaxis
was observed in only 0.9 per cent of the patients but
blood-stained nasal mucus was reported in 51 (17 per
cent). Aerophagia (leading to bloating and flatu-
Air leak Mask Skin breach Facial pain Sore eyes Skin reaction Nasal pain
discomfort
FIG. 2
Side-effects due to nasal mask.
890 A. KALAN, G. S. KENYON, T. A. R. SEEMUNGAL, J. A. WEDZICHA
Epistaxis Blood-stained Nasal
mucus blockage
Dry nosf Rhinorrhoea Sneezing Dry mouth
FIG. 3
Nasal side-effects.
lence) and symptoms suggestive of sinusitis was
recorded in only a minority of cases (0.4 per cent).
The CPAP machine was considered too cumber-
some and noisy by 135 (45 per cent) of the users
causing many partners to sleep separately (39 per
cent). One hundred and two (34 per cent) complained
of sleep disturbances as a result of the loud noise.
The type of nCPAP machine used was not
significantly related to the side-effects nor compli-
ance. Compliance was reduced in patients reporting
symptoms of dryness of the nose, leakage of air
around the mask or disturbed sleep due to noisy
equipment (p<0.02 in all cases). Also, patients were
less likely to use their nCPAP every night if they had
any of the following side-effects (rho, p): blood-
stained nasal mucus (—0.18, 0.002), noisy equipment
(-0.169, 0.004), epistaxis (-0.157, 0.008) or if they
slept separately (-0.248, <0.001).
No life-threatening symptoms such as meningitis,
pneumoencephaly or pneumothorax were seen,
although these have been previously reported
(Pepin et al, 1995).
Discussion
Sleep apnoea syndrome (SAS) is a life-threatening
condition characterized by repetitive episodes of
total or partial closure of the upper airways during
sleep resulting in episodic hypoxaemia and arousal
from sleep resulting in day-time somnolence. Nasal
continuous positive airway pressure (nCPAP), intro-
duced by Sullivan et al. in 1981, has become the
treatment of choice for the initial management of
SAS (Kryger, 1994). When used at night with an
appropriate applied pressure, nasal CPAP eliminates
Disturbed sleep Sleep separately
FIG. 4
Machine-related side-effects.
episodes of apnoea and hypopnoea due to upper
airways obstruction; the patient, therefore, enjoys
more undisturbed sleep and less subjective hyper-
somnolence while awake (Rajagopal et al., 1986).
CPAP has been shown to improve the long-term
prognosis by preventing cardiopulmonary sequelae
(Sullivan et al., 1981) although recent data does not
support this relationship (Shiner et al., 1990; Hoff-
stein et al., 1991; Levinson and Millman, 1991).
In this study we have shown a high incidence of
side-effects from the use of nCPAP. Adverse effects
were principally related to intolerance of the nasal
mask with the high rate of airflow leading to mucosal
inflammation in the nose, dryness and aerophagia.
The noise and bulk of the equipment was also a
disincentive to continued use.
Local side-effects related to the nasal mask have
been well described, both with nCPAP ,and inter-
mittent positive pressure ventilation (NIPPV) using
a nasal mask (Leger et al., 1992; Meecham Jones and
Wedzicha, 1994). It would seem, however, that the
type of mask used is of importance as reduced side-
effects have been reported in those using a tailor-
made mask. This is probably related to a better fit
and to a reduction in air leaks. Therefore, education
of the patient is important to obtain the best
adjustment of the mask and to reduce air leakage.
The greatest side-effect seems to be related to high
flow rates of air through the nose over long periods. In
theory humidification could reduce these side-effects
but in practice the use of humidification does not lead
to reduced problems (Pepin et al., 1995). This was
thought to be either due to inefficiency in the
humidification systems presently available or to the
lack of any effect from humidification whatever its
technical efficiency. NIPPV seems to lead to a lesser
degree of such side-effects, that may be due to the
cessation of positive air flow in the expiratory phase of
the respiratory cycle (Leger et al., 1992) or may be
due to differing flow rates since higher flow rates are
used with nCPAP compared with NIPPV (60 to 120
with nCPAP vs. 20 to 40 litres/minute with NIPPV).
Patients with SAS frequently complain of nasal
obstruction. This has been hypothesized as a possible
pre-existing condition leading to the development of
SAS (Series et al., 1993). Such problems may, in turn,
make the patients more susceptible to nasal side-
effects from the treatment compared with patients
requiring CPAP who do not have as many pre-
existing nasal disorders.
We found that some of the patients had to use
nocturnal sedatives for compliance despite contrary
medical advice and these patients more frequently
described problems with the noise of the machine.
This use of sedatives was possibly linked with the
poor quality of sleep, thus leading to a higher
perception of side-effects but, in spite of this, only a
few patients were unable to persist with the
treatment. In our study, none of the patients
required hospitalization because of serious side-
effects.
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Our study shows a similar level of side-effects to
those reported by Hoffstein et al. (1992). However,
recent data has suggested that the reported com-
pliance may be much higher than the real
compliance as others have found that only 46 per
cent of patients met the criteria for regular use,
denned as at least four hours of nCPAP adminis-
tered on 70 per cent of the nights monitored (Kribbs
et al., 1993). The same authors also found some
association between non-physical side-effects (claus-
trophobia) and less regular use of nCPAP but they
did not find any correlation between usage and the
physical side-effects.
The more recent CPAP devices have improved
design in that they are relatively quiet and are fitted
with modern masks that are self-sealing, light and
relatively comfortable. These improvements have
greatly reduced complications such as noise intoler-
ance, conjunctivitis due to air leaks and the
ulceration of the nasal bridge due to mask pressure.
In patients who cannot tolerate CPAP systems,
adjustments that increase the pressure slowly as the
patient falls asleep (the 'ramp device'), or those that
reduce the expiratory pressure (BiPAP) may be
helpful (Kryger, 1992). A damaged mask, increasing
weight, alcohol use, nasal obstruction or very rarely
machine failure can cause CPAP to fail late in the
course of therapy (Sullivan and Grunstein, 1994).
In summary, when patients have no surgically
remediable pathology, nCPAP is the method of
choice for the treatment of moderate to severe SAS.
Our study has shown that the incidence of side-effects
from this therapy is high but not that limiting as the
self-reported duration of use per night is excellent.
The treatment nevertheless remains acceptable to
most patients because of the derived benefits.
Improved design of masks and machines will alleviate
some of the difficulties in compliance but greater
awareness of the nasal side-effects is required. More
insight is also required as to the pathophysiology of
these symptoms, so that effective treatment strategies
can be designed to counteract them.
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Appendix I—The Questionnaire
Name D.O.B.
Please answer the following questions:
When did you start using your nCPAP machine?
Do you use your nCPAP machine every night?
No. of hours used each night
Do you currently suffer from any of the following?
Nasal blockage
Dryness in nose
Nose bleeds
Pain over bridge of nose
Excessive sneezing
Blood stained mucus from nose
Runny nose
Dry mouth in the mornings
Dizziness
Sore eyes
Facial pains
Eczema
Hayfever
Asthma
Yesn
Yesn
Yes n
Yesn
Y e s I I
Yes n
Yes n
Yesn
Yesn
Yesn
Yesn
Y e s I I
Age
Have you had any of the above problems in the past? (before starting CPAP treatment)
What is your experience of the following?
Noise of machine (Noisy) Yes n
Comfort of mask (Comfortable) Yes n
Air leaking from mask Yes n
Air leaking from your mouth Yes | |
Skin reaction to mask Yes | |
Breakdown of skin over nose (i.e. Pressure sore) Yes | |
Have you taken any inhalers/spray for nasal stuffiness? Yes n
Do you sleep in a separate room to your spouse/partner? Yes I I
No
Do you have sleep disturbance because of the nCPAP machine Yes n
Any other experiences/problems?
Sex
No | |
NO
N«n
N o | I
No n
N o D
No
Thank you for your time and co-operation in this study.
